Drug discovery services; Development of new technology for others in the field of neuroscience; Consulting services in the field of biotechnology; Research and development in the pharmaceutical and biotechnology fields; Biotechnology research in the field of neuroscience; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence for creating complex data science analyses; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for pharmacodynamic/pharmacokinetic insights, biomarker discovery, patient stratification, and target/drug discovery; Design and development of artificial intelligence (AI) software for pharmacodynamic/pharmacokinetic insights, biomarker discovery, patient stratification, and target/drug discovery

'ai':67,84 'aiaa':43 'analys':55 'artifici':38,48,65,82 'biomark':71,89 'biotechnolog':21,29,31 'complex':52 'consult':15 'creat':51 'data':53 'design':78 'develop':4,24,80 'discoveri':2,72,77,90,95 'drug':1 'featur':45,62 'field':12,19,30,35 'insight':70,88 'intellig':39,49,66,83 'neurosci':14,37 'new':6 'other':9 'patient':73,91 'pharmaceut':27 'pharmacodynamic/pharmacokinetic':69,87 'research':22,32 'saa':60 'scienc':54 'servic':3,16,42,44,59,61 'softwar':46,56,63,85 'stratif':74,92 'target/drug':76,94 'technolog':7 'use':47,64

MOSAIC NEUROSCIENCE

Owner

Goods & Services